GSK3B and lung cancer: However, Gln-supplemented animals exhibited an increase in phosphorylated GSK3b, suggesting an inactivation of GSK3b that has been recently shown to favor glutaminolysis and thus glutamine utilization as a carbon source in lung cancer cells [56].